Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Scopus BioPharma Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/01/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/26/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/17/2021 10-Q Quarterly Report for the period ended March 31, 2021
05/11/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/29/2021 10-K/A Annual Report for the period ended December 31, 2020 [amend]
04/06/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
03/29/2021 10-K Annual Report for the period ended December 31, 2020
03/18/2021 8-K Quarterly results
02/26/2021 10-Q/A Quarterly Report for the period ended September 30, 2020 [amend]
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2021 SC 13G HCFP/Capital Partners 18B-1 LLC reports a 10.3% stake in SCOPUS BIOPHARMA INC.
02/01/2021 8-K Quarterly results
02/01/2021 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
01/28/2021 10-Q Quarterly Report for the period ended September 30, 2020
01/27/2021 QUALIF Form QUALIF - Notice of Qualification [Regulation A]:
01/26/2021 1-A POS Form 1-A POS -
01/20/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Investor Presentation (January 2021)",
"Press Release"
01/15/2021 1-A POS Form 1-A POS -
12/28/2020 3 Hofstein Raphael (Director) has filed a Form 3 on Scopus BioPharma Inc.
12/28/2020 3 Russell Lesley (Director) has filed a Form 3 on Scopus BioPharma Inc.
12/28/2020 3 Weild IV David (Director) has filed a Form 3 on Scopus BioPharma Inc.
12/28/2020 3 Battleman David S. (Director) has filed a Form 3 on Scopus BioPharma Inc.
12/28/2020 3 Buckel David A. (Director) has filed a Form 3 on Scopus BioPharma Inc.
12/15/2020 3 Gibson Robert J (Vice Chairman) has filed a Form 3 on Scopus BioPharma Inc.
12/15/2020 3 Sanghrajka Ashish P (President) has filed a Form 3 on Scopus BioPharma Inc.
12/15/2020 3 Greenspan Ira Scott (Director) has filed a Form 3 on Scopus BioPharma Inc.
12/15/2020 3 Lamstein Joshua R (Chairman) has filed a Form 3 on Scopus BioPharma Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy